Related Experiment Video
Updated: Jul 25, 2026
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Role in tumorigenesis of silent mutations in the TP53 gene
1Department of Molecular Genetics and Cell Biology, The University of Chicago, 920 East 58th Street, 60637, Chicago, IL, USA. bs19@midway.uchicago.edu
Abstract:
Over 10,000 mutations in the TP53 suppressor gene have been recorded in the International Agency for Research on Cancer (IARC) tumor data base. About 4% of these mutations are silent. It is a question whether these mutations play a role in tumor development. In order to approach this question, we asked whether the reported silent mutations are randomly distributed throughout the TP53 gene. The p53 data base was searched exon by exon. From the frequency of codons with no silent mutations, the average number of silent mutations per codon for each exon was calculated using the Poisson distribution. The results indicate the distribution to be non-random. About one-third of all silent mutations occur in "hot-spots" and after subtraction of these hot-spots, the remaining silent mutations are randomly distributed. In addition, the percentage of silent mutations among the total in the silent mutation hot-spots is close to that expected for random mutation. We conclude that most of the silent mutations recorded in tumors play no role in tumor development and that the percentage of silent mutation is an indication of the amount of random mutation during tumorigenesis. Silent mutations occur to a significantly different extent in different tumor types. Tumors of the esophagus and colon have a low frequency of silent mutations, tumors of the prostate have a high frequency.
Insights
Most silent TP53 gene mutations in tumors are random and likely play no role in cancer development. However, specific "hot-spots" show non-random silent mutations, suggesting a role in tumorigenesis.
Area of Science:
- Genetics
- Oncology
- Bioinformatics
Background:
- The TP53 tumor suppressor gene is frequently mutated in human cancers.
- Silent mutations, which do not alter protein sequence, account for approximately 4% of TP53 mutations.
- The functional significance of silent TP53 mutations in tumorigenesis remains unclear.
Purpose of the Study:
- To investigate the distribution pattern of silent mutations within the TP53 gene.
- To determine if silent mutations are randomly distributed or concentrated in specific regions.
- To assess the potential role of silent mutations in tumor development.
Main Methods:
- Analysis of the International Agency for Research on Cancer (IARC) TP53 mutation database.
- Exon-by-exon examination of silent mutation frequencies.
- Calculation of average silent mutations per codon using the Poisson distribution.
- Identification and analysis of silent mutation "hot-spots".
Main Results:
- The distribution of silent TP53 mutations across the gene is non-random.
- Approximately one-third of all silent mutations are located in specific "hot-spots".
- After accounting for hot-spots, the remaining silent mutations are randomly distributed.
- Silent mutation frequencies vary significantly across different tumor types, with prostate tumors showing high frequency and esophageal/colon tumors showing low frequency.
Conclusions:
- The majority of recorded silent TP53 mutations in tumors are likely random occurrences with no direct role in cancer development.
- The percentage of silent mutations can serve as an indicator of random mutation levels during tumorigenesis.
- Specific silent mutation hot-spots may be associated with tumor development, warranting further investigation.
Related Concept Videos
02:23Abnormal Proliferation
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...